Advisor Net Financial, Inc Mesoblast LTD Transaction History

Advisor Net Financial, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 14, 2021	SELL	$8.26 - $11.4 $75,166 - $103,740	-9,100 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$11.33 - $19.81 $36,256 - $63,391	-3,200 Reduced 26.02%	9,100 $169,000
Q2 2020 Aug 26, 2020	SELL	$4.2 - $15.45 $6,300 - $23,175	-1,500 Reduced 10.87%	12,300 $140,000
Q3 2019 Oct 23, 2019	BUY	$4.68 - $7.42 $27,144 - $43,036	5,800 Added 72.5%	13,800 $96,000
Q1 2018 May 08, 2018	BUY	$4.91 - $7.72 $39,280 - $61,760	8,000 New	8,000 $46,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.